Home > Boards > US Listed > Biotechs > Acadia Pharmaceuticals Inc. (ACAD)

I’ve been adding to my position on the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
LasNubes Member Profile
 
Followed By 37
Posts 2,386
Boards Moderated 0
Alias Born 04/07/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2021 6:07:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2021 6:37:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2021 6:36:27 PM
Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campaign to Bring Greater Awareness to Parkinson’s Disease Non-Motor Symptoms Business Wire - 11/16/2021 9:00:00 AM
ACADIA Pharma at a three-month high ahead of key update on dementia therapy Seeking Alpha - 11/9/2021 2:47:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2021 6:02:47 AM
Acadia's narrows full-year guidance for Nuplazid sales, but shares rise after-hours Seeking Alpha - 11/8/2021 4:24:25 PM
ACADIA Pharma EPS beats by $0.17, beats on revenue Seeking Alpha - 11/8/2021 4:24:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2021 4:16:26 PM
Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results Business Wire - 11/8/2021 4:05:00 PM
ACADIA Pharma Q3 2021 Earnings Preview Seeking Alpha - 11/7/2021 4:35:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/5/2021 4:43:50 PM
Acadia Pharmaceuticals Presents New Dementia-Related Psychosis Real-World Outcomes Data at Psych Congress 2021 Business Wire - 11/2/2021 9:00:00 AM
Acadia Pharma appoints Brendan Teehan as COO, effective immediately Seeking Alpha - 11/1/2021 5:29:33 PM
Acadia Pharmaceuticals Appoints Brendan Teehan, Executive Vice President, Chief Operating Officer, Head of Commercial Business Wire - 11/1/2021 4:05:00 PM
Acadia Pharma gains as Guggenheim upgrades ahead of the key data readout Seeking Alpha - 11/1/2021 12:19:38 PM
Acadia Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 8, 2021 Business Wire - 10/27/2021 9:00:00 AM
Acadia Pharmaceuticals to Present Data on Pimavanserin in Patients with Parkinson’s Disease Dementia with Psychosis from the HARMONY trial at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Conference Business Wire - 10/25/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 5:32:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2021 5:31:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2021 5:34:13 PM
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - 9/2/2021 9:00:00 AM
Acadia Pharmaceuticals Announces Executive Leadership Change Business Wire - 9/1/2021 4:05:00 PM
Dermata therapeutics appoints Kyri Van Hoose as CFO Seeking Alpha - 9/1/2021 6:55:32 AM
Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 Business Wire - 8/5/2021 4:05:00 PM
LasNubes   Wednesday, 08/11/21 08:56:24 AM
Re: None
Post # of 3051 
I’ve been adding to my position on the re-trace.

Excited to see upcoming results and execution on pipeline assets in the near future.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences